Close

AnaptysBio (ANAB) PT Lowered to $153 at JMP Securities Aug 15, 2018 04:45AM
Anaptysbio (ANAB) Target Reintroduced at JMP Following Positive POC Data in Peanut Allergy for ANB020 Mar 27, 2018 03:21AM
AnaptysBio to Participate in Upcoming Investor Conferences Jun 1, 2017 06:30AM
JMP Reiterates Market Outperform Rating and $45 PT on AnaptysBio (ANAB); Dupixent Approval Positive for ANB020 Mar 30, 2017 08:44AM
UPDATE: JMP Securities Starts AnaptysBio (ANAB) at Market Outperform Feb 21, 2017 03:04AM


Jan 31, 2017 05:00PM AnaptysBio Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 26, 2017 10:54AM AnaptysBio (ANAB) IPO Opens Up 7%
Jan 26, 2017 05:52AM AnaptysBio (ANAB) IPO Prices at $15
Jan 25, 2017 07:00PM AnaptysBio Announces Pricing of Initial Public Offering